Showing 401 - 420 results of 21,625 for search '(( significant decrease decrease ) OR ( significant ((sharp increase) OR (we decrease)) ))*', query time: 0.59s Refine Results
  1. 401
  2. 402
  3. 403
  4. 404

    Table 1_Overexpression of TaPSKR1L-6A improves resistance to sharp eyespot and increases lignin accumulation in wheat.docx by Haijun Qi (11611600)

    Published 2025
    “…Overexpression of TaPSKR1L-6A significantly increased sheath blight resistance, upregulated the expression of lignin synthesis and metabolism pathway genes, and increased lignin accumulation, which was opposite to the results of silencing TaPSKR1L-6A. …”
  5. 405
  6. 406

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
  7. 407

    Grade system. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
  8. 408
  9. 409
  10. 410
  11. 411
  12. 412
  13. 413
  14. 414
  15. 415
  16. 416

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  17. 417

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  18. 418
  19. 419
  20. 420

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

    Published 2025
    “…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”